Ballad Research Institute
- Assets
- $520.0k
- Revenue
- $289.3k
- Investments
- $0.0
- Employees
- 0
- Location
- San Diego, CA
- Founding
- 07/2014
- Data as of
- 06/2022
- EIN
- 46-3097024
Organization Overview
Ballad Research Institute is located in San Diego, CA. The organization was established in 2014. According to its NTEE Classification (U05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Science & Technology and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ballad Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Ballad Research Institute generated $289.3k in total revenue. All expenses for the organization totaled $292.1k during the year ending 06/2022. While expenses have increased by 32.8% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF BALLAD IS TO SUPPORT THE EARLY DEVELOPMENT OF PROJECTS RELATED TO THE TREATMENT OF HUMAN DISEASE. THESE MAY INCLUDE PILOT STUDIES, INNOVATIVE HIGH-RISK/HIGH-IMPACT PROJECTS, OR PROOF OF CONCEPT STUDIES. BALLAD PROVIDES INVESTIGATORS, EMABARKING ON EARLY DEVELOPMENT PROJECTS, WITH NECESSARY LABORATORY FACILITIES AND INFRASTRUCTURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
BALLAD SCIENTISTS HAVE IDENTIFIED A NEW IMMUNE CELL TYPE IN HUMAN BLOOD. CHILDREN WHO ARE DIAGNOSED WITH RAPIDLY PROGRESSING TYPE 1 DIABETES HAVE VERY FEW OF THESE CELLS BUT CHILDREN WITH LESS SEVERE DIABETES HAVE ALMOST NORMAL NUMBERS. MORE RECENTLY BALLAD SCIENTISTS HAVE FOUND THAT THE CELLS THEY HAVE DISCOVERED HAVE THE CAPACITY TO ACTIVELY INHIBIT INFLAMMATION. THIS IS IMPORTANT BECAUSE DIABETES IS AN INFLAMMATORY DISEASE AND THIS MIGHT EXPLAIN WHY HAVING FEW OF THESE CELLS IS ASSOCIATED WITH WORSE DISEASE. THE NEXT STEP IN THEIR RESEARCH IS TO UNDERSTAND HOW TO MAKE MORE OF THESE CELLS AS A WAY OF SLOWING PROGRESSION, OR REVERSING THIS DEVASTATING DISEASE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Joanna Davies Chair | OfficerTrustee | 1 | $0 |
Sheila Ferguson Treasurer | OfficerTrustee | 1 | $0 |
Mark Hargreaves Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $289,346 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $289,346 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $289,346 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $95,109 |
| Pension plan accruals and contributions | $7,191 |
| Other employee benefits | $12,044 |
| Payroll taxes | $8,614 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $9,680 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $550 |
| Advertising and promotion | $0 |
| Office expenses | $6 |
| Information technology | $180 |
| Royalties | $0 |
| Occupancy | $27,518 |
| Travel | $3,448 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,667 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $292,065 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $409,569 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $102,098 |
| Net Land, buildings, and equipment | $8,333 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $520,000 |
| Accounts payable and accrued expenses | $550 |
| Grants payable | $0 |
| Deferred revenue | $514,326 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $514,876 |
| Net assets without donor restrictions | $5,124 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $520,000 |